31 results
Page 2 of 2
424B5
z2fr1k3568b0
24 Feb 21
Prospectus supplement for primary offering
5:16pm
6-K
ncsqzb6
24 Feb 21
Current report (foreign)
4:16pm
6-K
EX-99.2
n94kgh5ih0c
11 Jan 21
InflaRx Provides Update on Vilobelimab (IFX-1) Development
7:30am
6-K
EX-99.1
rbjnfgvr7qd8cxbu2
11 Jan 21
InflaRx Provides Update on Vilobelimab (IFX-1) Development
7:30am
424B5
1h23dx
20 Jul 20
Prospectus supplement for primary offering
9:21am
20-F/A
1zjz7 0qumit
29 Mar 19
Annual report (foreign) (amended)
4:23pm
424B4
i9xxqweu
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
brnzr
2 May 18
Registration statement (foreign)
7:10am
20-F
iyx1fx3 7wfyhd
29 Mar 18
Annual report (foreign)
12:00am